Is Medvi Reputable? A Complete Trust and Reliability Review

Last updated: October 13, 2026

Quick Answer: Medvi is a legitimate telehealth company offering compounded GLP-1 medications like semaglutide and tirzepatide, with a strong Trustpilot rating and a large base of satisfied users. However, the company carries notable red flags, including a February 2026 FDA warning letter, an unaccredited BBB profile with recurring billing complaints, and ongoing regulatory scrutiny that prospective patients should weigh carefully before enrolling.

---

Key Takeaways

• Medvi is a real telehealth platform offering compounded GLP-1 weight-loss medications, not a scam
• The company holds a strong Trustpilot rating based on thousands of reviews, with many users reporting meaningful weight loss [3]
• A February 2026 FDA warning letter cited misbranding and non-approved compounded drug concerns, which is a significant compliance issue
• The BBB profile for Medvi shows an unaccredited status with recurring complaints about billing, refunds, and cancellation difficulties [5]
• Medvi is separate from Medvidi Inc., a mental-health telehealth company that shares a similar name but is a completely different business [4]
• Pricing for GLP-1 programs is competitive with other telehealth platforms, though long-term costs add up
• Patients report strong clinical results but inconsistent customer service experiences
• The platform is best suited for adults who want affordable access to compounded GLP-1 medications without insurance
• Anyone with complex medical histories or who needs hands-on support should consider alternatives

---

What Does Medvi Do and What Services Do They Offer

Medvi is a telehealth platform that connects patients with licensed physicians to prescribe compounded GLP-1 medications, primarily compounded semaglutide and tirzepatide, for weight management. The service operates entirely online, from the initial consultation through prescription fulfillment and ongoing check-ins.

Here is what Medvi’s core service model includes:

• Online medical consultation: Patients complete a health intake form and are reviewed by a licensed provider
• Compounded GLP-1 prescriptions: Semaglutide and tirzepatide in injectable and, more recently, oral tablet form
• Pharmacy fulfillment: Medications are shipped directly to the patient’s home from compounding pharmacies
• Ongoing coaching and check-ins: Some plans include access to health coaches and provider follow-ups
• Subscription-based model: Most patients pay monthly or quarterly for continued access to medication and provider oversight

For a deeper look at specific medication options, see the Medvi oral tirzepatide reviews and the breakdown of Medvi tirzepatide tablets to understand what the platform currently offers.

The company targets adults who are overweight or obese and want access to GLP-1 therapy without navigating insurance barriers or the high retail cost of brand-name drugs like Ozempic or Wegovy. Medvi’s model is built around affordability and convenience, which appeals strongly to the growing market of self-pay weight-loss patients.

Start your Medvi GLP-1 journey today

---

Is Medvi Legitimate or a Scam

Medvi is a legitimate company, not a scam. It operates with licensed physicians, uses real compounding pharmacies, and has thousands of verified patient reviews across multiple platforms [3][7].

That said, “legitimate” does not mean “without issues.” Here is an honest breakdown:

Evidence supporting legitimacy:

• Thousands of verified Trustpilot reviews with a high aggregate rating [3]
• Licensed healthcare providers conduct consultations
• Medications are dispensed through compounding pharmacies, not manufactured in unregulated facilities
• The company has been covered by mainstream outlets including USA Today [7]
• A large and growing patient base with documented weight-loss outcomes

Concerns that warrant attention:

• The FDA issued a warning letter to Medvi in February 2026 related to misbranding and the distribution of non-approved compounded drugs. This is a serious regulatory action, not a minor administrative note.
• The BBB profile for Medvi shows an unaccredited status with multiple unresolved complaints [5]
• Some users on Reddit and consumer review sites describe difficulty canceling subscriptions and obtaining refunds [1][2]

The bottom line: Medvi ships real medication prescribed by real doctors. But the FDA warning and billing complaints mean patients should go in with clear expectations and read the cancellation terms before enrolling.

---

Medvi Company Reviews and Customer Ratings

Medvi’s Trustpilot profile shows a strong overall rating based on a large volume of reviews, making it one of the more reviewed telehealth weight-loss platforms in this category [3]. The majority of reviewers report positive clinical experiences, including significant weight loss and responsive initial consultations.

What positive reviewers consistently say:

• Noticeable weight loss within the first 1-3 months
• Easy onboarding process and fast prescription approval
• Medication arrived discreetly and on schedule
• Affordable compared to brand-name GLP-1 options

What critical reviewers flag:

• Billing charges continuing after cancellation requests [2]
• Difficulty reaching customer support to resolve issues
• Some users report receiving medication that differed from what was described
• Occasional shipping delays without proactive communication [6][8][9][10]

One Reddit user who documented 10 months of use described Medvi as better than expected overall, citing consistent weight loss and manageable side effects, while noting that the customer service experience was the weakest part of the program [1].

On ConsumerAffairs, the picture is more mixed, with a meaningful share of reviewers specifically citing billing and refund frustrations [2]. This contrast between strong clinical outcomes and weaker operational support is a recurring theme across review platforms.

For a fuller picture of what real users are saying, the Medvi reviews and Medvi meds reviews and complaints pages compile user experiences in one place.

See if Medvi is right for you

---

Medvi Complaints and Negative Reviews

The most common complaints about Medvi center on three operational areas: billing disputes, refund difficulties, and cancellation challenges.

Top complaint themes from verified sources:

Complaint Category	Frequency	Source
Billing after cancellation	High	BBB, ConsumerAffairs [2][5]
Refund delays or denials	High	BBB [5]
Poor customer service responsiveness	Moderate	Trustpilot [6][8]
Shipping delays	Moderate	Trustpilot [9][10]
Medication discrepancies	Lower	Reddit [1]

The BBB profile for Medvi (registered in Newark, Delaware) shows multiple complaints filed, with several citing unresolved billing issues [5]. It is worth noting that Medvi is distinct from Medvidi Inc., a California-based mental-health telehealth company with its own separate BBB profile [4]. Consumers sometimes confuse the two because of the similar names, so always verify you are reviewing the correct company.

The FDA warning letter from February 2026 is the most serious concern on record. It specifically cited misbranding and the distribution of compounded drugs that had not received the required regulatory approvals. Medvi has not publicly disclosed how it has addressed this warning as of October 2026, which is something prospective patients should ask about directly before signing up.

---

Medvi Pricing and Cost Comparison

Medvi’s pricing is competitive within the compounded GLP-1 telehealth market, though exact costs vary by medication type, dosage tier, and subscription plan. Long-term users report monthly costs that are significantly lower than brand-name alternatives like Ozempic or Wegovy, which can exceed $900 per month without insurance.

For a detailed breakdown of what patients actually pay over time, the Medvi tirzepatide monthly cost page provides a thorough cost analysis. You can also compare against the broader market with this tirzepatide cost review.

General pricing structure (based on user-reported experiences):

• Compounded semaglutide programs: typically in the range of $150-$300 per month depending on dose
• Compounded tirzepatide programs: generally higher, reflecting the newer medication class
• Oral tirzepatide tablet options: a newer, lower-cost entry point for patients who prefer non-injectable forms
• Subscription discounts are available for quarterly or longer commitments

Comparison with similar platforms:

Medvi’s pricing sits in a similar range to competitors like Hims, Henry Meds, and Mochi Health. For context, you can review how Medvi stacks up by reading the Hims weight loss review, the Henry Meds semaglutide review, and the Mochi Health review.

Check current Medvi pricing and plans

---

Medvi Licensing, Certifications, and How Long It Has Been in Business

Medvi operates as a telehealth company with licensed physicians conducting consultations across multiple states. The company is relatively young, having grown rapidly alongside the broader GLP-1 medication boom that accelerated after 2022.

What is confirmed about Medvi’s credentials:

• Consultations are conducted by licensed medical providers
• Medications are fulfilled through compounding pharmacies, which are regulated under state pharmacy boards and, at the federal level, by the FDA
• The company is registered as a business entity in Delaware

What remains unclear or concerning:

• The February 2026 FDA warning letter raises questions about whether the compounding pharmacies Medvi partners with fully comply with federal standards for non-patient-specific compounded drugs
• Medvi does not prominently display specific pharmacy accreditation information (such as PCAB accreditation) on its public-facing materials
• The BBB profile is unaccredited, meaning Medvi has not sought or maintained BBB accreditation [5]

For anyone researching prescription weight-loss options broadly, the RX medications for weight loss complete 2026 guide provides important regulatory context about how compounded GLP-1 drugs are classified and what the FDA’s evolving stance means for patients.

---

Who Should Use Medvi and Who Should Not

Medvi is a reasonable option for a specific type of patient, but it is not the right fit for everyone.

Medvi is likely a good fit if you:

• Are an adult with a BMI that qualifies for GLP-1 therapy and have no major contraindications
• Want affordable access to compounded semaglutide or tirzepatide without using insurance
• Are comfortable with a primarily digital experience and minimal in-person interaction
• Have researched GLP-1 medications and understand the commitment involved
• Are organized about tracking your own subscription and billing carefully

Medvi is probably not the right choice if you:

• Have complex medical histories, multiple medications, or conditions that require close physician oversight
• Need hands-on, responsive customer support as a priority
• Are uncomfortable with the regulatory uncertainty around compounded GLP-1 drugs post-FDA warning
• Have had negative experiences with telehealth subscription billing practices
• Prefer a platform with transparent pharmacy accreditation information

A note on the FDA warning: The February 2026 warning letter does not mean Medvi’s medications are unsafe for every patient, but it does mean the regulatory status of some products is under scrutiny. Patients who are risk-averse or who have underlying health conditions should discuss this specifically with their own physician before enrolling.

Find out if you qualify for Medvi GLP-1

---

Medvi Refund Policy and Common Mistakes Patients Make

Medvi’s refund policy has been a consistent source of complaints, and understanding it before you subscribe is one of the most important steps you can take.

What users report about refunds:

• Refunds for unused medication portions are not straightforward and often require direct escalation [2][5]
• Cancellation requests submitted through the app or email do not always stop billing immediately, according to multiple BBB complaints [5]
• Some users report being charged for a new cycle after submitting a cancellation request

Common mistakes patients make with Medvi:

1. Assuming the cancellation process is instant. It is not. Follow up in writing and keep records.
2. Not reading the subscription terms before enrolling, particularly around auto-renewal timing.
3. Confusing Medvi with Medvidi Inc. when searching for reviews. Medvidi is a separate mental-health telehealth company with its own BBB profile [4].
4. Expecting brand-name medication. Medvi prescribes compounded versions, which are chemically similar but not FDA-approved finished drug products.
5. Not asking the provider directly about which compounding pharmacy will fulfill the prescription and whether it holds relevant accreditations.

---

Medvi Security and Data Privacy Concerns

As a telehealth provider, Medvi collects sensitive personal health information, including medical history, weight, and prescription data. Patients should understand how this data is handled.

What to look for:

• Telehealth platforms operating in the US are generally subject to HIPAA, which sets baseline standards for health data privacy
• Medvi’s privacy policy should outline data retention, sharing with third parties, and patient rights
• Patients should review whether Medvi shares data with marketing partners, a practice that some telehealth companies use to offset costs

There are no widely reported data breach incidents associated with Medvi as of October 2026. However, given the company’s rapid growth and the sensitivity of the data it handles, patients should read the privacy policy carefully and use strong, unique passwords for their patient portal accounts.

---

Medvi Better Alternatives and Competitors

If Medvi’s FDA warning letter or billing complaints give you pause, several well-established telehealth platforms offer similar GLP-1 programs with different risk profiles.

Top alternatives to consider:

• Hims: A large, publicly traded telehealth company with a broader service range. See the Hims semaglutide review for a detailed comparison.
• Henry Meds: Known for competitive pricing on compounded semaglutide. The Henry Meds semaglutide review covers the pros and cons.
• Mochi Health: Offers a more clinically intensive model with dietitian support. Covered in the Mochi Health review.
• Measured GLP-1: A newer entrant with a data-driven approach. See the Measured GLP-1 review 2026.
• Ro Body: Another established telehealth option. The Ro Body review provides a useful comparison point.

Choose Medvi if: You want a lower entry cost, are comfortable managing your own subscription carefully, and have done your due diligence on the FDA situation.

Choose an alternative if: You prioritize regulatory clarity, responsive customer service, or a more clinically supported program structure.

Compare Medvi with top GLP-1 platforms

---

Medvi Semaglutide and Tirzepatide: What the Clinical Experience Actually Looks Like

The clinical side of Medvi’s offering is where the platform earns most of its positive reviews. Users who stay on the program and tolerate the medication well report meaningful weight loss, often in the range of 10-20% of body weight over 6-12 months, which aligns with published clinical trial data for GLP-1 receptor agonists.

For medication-specific experiences, the Medvi semaglutide reviews page and the Medvi quad overview cover the different formulation options the platform offers.

What clinical users commonly report:

• Reduced appetite within the first 2-4 weeks of starting semaglutide
• More gradual appetite suppression with tirzepatide, with stronger effects at higher doses
• Nausea and GI side effects are common in the first 4-8 weeks, consistent with known GLP-1 side effect profiles
• Most users who stick with the program for 3+ months report sustained weight loss [1][7]

The gap between clinical satisfaction and operational frustration is real at Medvi. Many patients are genuinely happy with their weight-loss results but frustrated by the administrative side of the experience. That contrast is worth keeping in mind as you evaluate whether the platform is right for you.

Start losing weight with Medvi GLP-1 today

---

Conclusion

So, is Medvi a reputable company? The honest answer is: partially. Medvi is a real, operational telehealth company with licensed providers, real medications, and thousands of patients who have lost meaningful weight using its GLP-1 programs. That is not nothing. For many self-pay patients who cannot afford brand-name Ozempic or Wegovy, Medvi has been a genuinely useful option.

At the same time, the February 2026 FDA warning letter, the unaccredited BBB profile, and the recurring billing complaints are not minor footnotes. They represent real operational and regulatory weaknesses that any informed patient should factor into their decision.

Actionable next steps:

1. Read the full subscription and cancellation terms before enrolling, and save a copy
2. Ask Medvi directly which compounding pharmacy will fulfill your prescription and whether it holds PCAB accreditation
3. Monitor your billing statements closely in the first 90 days
4. If you have complex health conditions, consult your own physician before starting any GLP-1 program
5. Compare at least one or two alternatives before committing, using the reviews linked throughout this article

If you decide Medvi is the right fit after doing that homework, the clinical evidence suggests it can deliver real results. Go in informed, protect your billing, and you give yourself the best chance of a positive experience.

Get started with Medvi GLP-1 here

---

Frequently Asked Questions

Is Medvi a legitimate company or a scam?
Medvi is a legitimate telehealth company, not a scam. It employs licensed physicians and ships real compounded GLP-1 medications. However, a February 2026 FDA warning letter and recurring billing complaints mean patients should proceed with caution and read all terms carefully.

What medications does Medvi prescribe?
Medvi primarily prescribes compounded semaglutide and compounded tirzepatide, available in injectable and oral tablet forms. These are compounded versions of the active ingredients in brand-name drugs like Ozempic, Wegovy, and Zepbound.

How does Medvi’s Trustpilot rating compare to competitors?
Medvi holds a strong Trustpilot rating based on a large review volume, which is competitive with other telehealth GLP-1 platforms [3]. However, the BBB profile tells a more mixed story, with multiple unresolved billing complaints [5].

Is Medvi the same as Medvidi?
No. Medvi and Medvidi Inc. are two completely separate companies. Medvidi Inc. is a California-based mental-health telehealth service with its own BBB profile [4]. Confusing the two when reading reviews is a common mistake.

What did the FDA warning letter say about Medvi?
The February 2026 FDA warning letter cited misbranding and the distribution of non-approved compounded drugs. This is a serious regulatory action that raises questions about compliance at Medvi and its partner pharmacies.

How much does Medvi cost per month?
Based on user-reported experiences, compounded semaglutide programs typically run in the $150-$300 per month range, with tirzepatide programs generally costing more. Exact pricing varies by dose and subscription length.

Can I cancel my Medvi subscription easily?
Cancellation has been a recurring complaint. Multiple users report that cancellation requests did not immediately stop billing [2][5]. Always submit cancellation in writing, keep a record, and follow up to confirm.

Who should not use Medvi?
Patients with complex medical histories, multiple medications, or conditions requiring close physician oversight should be cautious. Anyone who values highly responsive customer service or wants full regulatory clarity on their medication source should consider alternatives.

How long does it take to see results with Medvi GLP-1?
Most users report reduced appetite within 2-4 weeks and noticeable weight loss within the first 1-3 months, consistent with clinical data for GLP-1 receptor agonists [1][7].

Does Medvi accept insurance?
Medvi primarily operates as a self-pay platform. Compounded GLP-1 medications are generally not covered by insurance, which is part of why the lower cost compared to brand-name drugs is a key selling point.

---

References

[1] Medvi Review After 10 Months Of Use Better Than I – https://www.reddit.com/r/tirzepatidecompound/comments/1lcyorl/medvi_review_after_10_months_of_use_better_than_i/

[2] Medvi – https://www.consumeraffairs.com/health/medvi.html

[3] Medvi – https://www.trustpilot.com/review/medvi.org

[4] Customer Reviews (Medvidi Inc.) – https://www.bbb.org/us/ca/san-jose/profile/mental-health-services/medvidi-inc-1216-1647461/customer-reviews

[5] Customer Reviews (Medvi) – https://www.bbb.org/us/de/newark/profile/medical-consultants/medvi-0251-92034163/customer-reviews

[6] Medvi Trustpilot Page 9 – https://www.trustpilot.com/review/medvi.org?page=9

[7] USA Today – Medvi – https://www.usatoday.com/story/life/health-wellness/medvi-reviews/90183552007/

[8] Medvi Trustpilot Page 3 – https://www.trustpilot.com/review/medvi.org?page=3

[9] Medvi Trustpilot Page 4 – https://www.trustpilot.com/review/medvi.org?page=4

[10] Medvi Trustpilot Page 7 – https://www.trustpilot.com/review/medvi.org?page=7

---